M1 Kliniken AG (ETR: M12)
Germany
· Delayed Price · Currency is EUR
15.75
-0.15 (-0.94%)
Dec 20, 2024, 5:36 PM CET
M1 Kliniken AG Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Revenue | 333.27 | 316.32 | 285.29 | 314.61 | 159.59 | 77.22 | Upgrade
|
Revenue Growth (YoY) | 12.05% | 10.88% | -9.32% | 97.14% | 106.68% | 18.42% | Upgrade
|
Cost of Revenue | 293.68 | 283.85 | 254.06 | 281.89 | 139.79 | 58.23 | Upgrade
|
Gross Profit | 39.59 | 32.47 | 31.23 | 32.72 | 19.8 | 18.98 | Upgrade
|
Selling, General & Admin | 1.98 | 1.98 | 1.66 | 1.67 | 1.85 | 1.3 | Upgrade
|
Other Operating Expenses | 10.63 | 10.54 | 14.57 | 13.23 | 9.07 | 6.47 | Upgrade
|
Operating Expenses | 17.75 | 17.83 | 22.29 | 20.59 | 15.4 | 11.17 | Upgrade
|
Operating Income | 21.84 | 14.64 | 8.94 | 12.14 | 4.4 | 7.81 | Upgrade
|
Interest Expense | -1.79 | -1.35 | -0.83 | -0.92 | -0.72 | -0.34 | Upgrade
|
Interest & Investment Income | 2.1 | 2.1 | 1.5 | 1.87 | 0.3 | 1.85 | Upgrade
|
Earnings From Equity Investments | - | - | - | - | 1.92 | - | Upgrade
|
Currency Exchange Gain (Loss) | -0.07 | -0.07 | -0.07 | -0.3 | -0.18 | 0.05 | Upgrade
|
Other Non Operating Income (Expenses) | 0.01 | 0.01 | 0.26 | 0.04 | 0.01 | 0 | Upgrade
|
EBT Excluding Unusual Items | 22.09 | 15.33 | 9.81 | 12.84 | 5.73 | 9.37 | Upgrade
|
Gain (Loss) on Sale of Investments | 1.28 | -0 | 0.22 | 1.33 | -1.83 | 3.31 | Upgrade
|
Gain (Loss) on Sale of Assets | 0.97 | 0.97 | 0.01 | 0.01 | -0.35 | - | Upgrade
|
Other Unusual Items | - | - | - | - | 5.08 | - | Upgrade
|
Pretax Income | 24.49 | 16.45 | 10.23 | 14.42 | 8.78 | 12.74 | Upgrade
|
Income Tax Expense | 6.39 | 4.78 | 3.16 | 3.54 | 1.35 | 3.02 | Upgrade
|
Earnings From Continuing Operations | 18.09 | 11.67 | 7.07 | 10.88 | 7.42 | 9.73 | Upgrade
|
Minority Interest in Earnings | -1.33 | -1.39 | -2.75 | -1.97 | -0.6 | - | Upgrade
|
Net Income | 16.76 | 10.27 | 4.32 | 8.91 | 6.82 | 9.73 | Upgrade
|
Net Income to Common | 16.76 | 10.27 | 4.32 | 8.91 | 6.82 | 9.73 | Upgrade
|
Net Income Growth | 163.65% | 137.98% | -51.52% | 30.52% | -29.87% | 47.13% | Upgrade
|
Shares Outstanding (Basic) | 18 | 19 | 18 | 19 | 19 | 18 | Upgrade
|
Shares Outstanding (Diluted) | 18 | 19 | 18 | 19 | 19 | 18 | Upgrade
|
Shares Change (YoY) | -0.55% | 4.43% | -1.43% | -0.02% | 6.19% | 4.09% | Upgrade
|
EPS (Basic) | 0.91 | 0.54 | 0.24 | 0.48 | 0.37 | 0.56 | Upgrade
|
EPS (Diluted) | 0.91 | 0.54 | 0.24 | 0.48 | 0.37 | 0.56 | Upgrade
|
EPS Growth | 165.12% | 127.89% | -50.82% | 30.54% | -33.96% | 41.35% | Upgrade
|
Free Cash Flow | 19.71 | 7.35 | 19.61 | 14.66 | 8.63 | -6.43 | Upgrade
|
Free Cash Flow Per Share | 1.07 | 0.38 | 1.07 | 0.79 | 0.46 | -0.37 | Upgrade
|
Dividend Per Share | 0.500 | 0.500 | - | - | - | - | Upgrade
|
Gross Margin | 11.88% | 10.27% | 10.95% | 10.40% | 12.41% | 24.58% | Upgrade
|
Operating Margin | 6.55% | 4.63% | 3.14% | 3.86% | 2.76% | 10.12% | Upgrade
|
Profit Margin | 5.03% | 3.25% | 1.51% | 2.83% | 4.28% | 12.60% | Upgrade
|
Free Cash Flow Margin | 5.91% | 2.33% | 6.87% | 4.66% | 5.41% | -8.33% | Upgrade
|
EBITDA | 24.96 | 17.93 | 10.6 | 14.42 | 5.72 | 9.09 | Upgrade
|
EBITDA Margin | 7.49% | 5.67% | 3.71% | 4.58% | 3.58% | 11.77% | Upgrade
|
D&A For EBITDA | 3.12 | 3.29 | 1.65 | 2.29 | 1.32 | 1.27 | Upgrade
|
EBIT | 21.84 | 14.64 | 8.94 | 12.14 | 4.4 | 7.81 | Upgrade
|
EBIT Margin | 6.55% | 4.63% | 3.14% | 3.86% | 2.76% | 10.12% | Upgrade
|
Effective Tax Rate | 26.11% | 29.06% | 30.91% | 24.57% | 15.41% | 23.66% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.